Comparison 9. Amodiaquine (AQ) vs chloroquine (CQ).

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Treatment failure at day 28	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
2 Treatment failure at day 28 (excludes new infections, detected by PCR)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
3 Adverse events	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
3.1 Any "side effect" at day 3	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.2 Any "side effect" at day 7	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.3 General weakness at day 3	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.4 General weakness at day 7	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.5 Dizziness at day 3	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.6 Dizziness at day 7	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.7 Vomiting at day 3	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.8 Vomiting at day 7	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.9 Itching at day 3	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.10 Itching at day 7	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.11 Nausea at day 3	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.12 Nausea at day 7	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4 Low birthweight	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
5 Preterm delivery	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected